Analysis of Urea Levels in Chronic Kidney Disease Patients Based on Age, Sex, and Hemodialysis Frequency
DOI:
https://doi.org/10.51601/ijhp.v6i2.614Abstract
Introduction: Chronic kidney disease (CKD) is a progressive condition characterized by declining renal function and accumulation of metabolic waste such as urea. Hemodialysis is essential in advanced CKD to reduce urea levels, which serve as an important marker for renal function and dialysis adequacy. Variations in urea levels may be influenced by demographic factors such as age and sex, as well as treatment-related factors including hemodialysis frequency. Aims: This study aimed to analyze urea levels and hemodialysis frequency among CKD patients based on age groups (<50 years, 51–60 years, and ≥61 years) and sex. Methods: A descriptive quantitative study with a cross-sectional design was conducted using secondary data from medical records of CKD patients undergoing hemodialysis at PKU Muhammadiyah Gamping Hospital from 2021 to 2023. A total of 78 complete records were included. Urea levels and hemodialysis frequency were analyzed descriptively, and an independent t-test was used to assess differences between male and female patients. Results: Urea levels varied across age groups within each sex. In males, the highest mean urea level was observed in the 51–60 years group, while females showed a progressive increase with age. Male patients exhibited greater variability, especially in older age groups, whereas females showed more consistent patterns. Hemodialysis frequency remained relatively stable in males but increased with age in females. However, statistical analysis revealed no significant difference in urea levels between sexes (p = 0.919), with mean values of 99.35 mg/dL in males and 100.38 mg/dL in females. Conclusion: Urea levels in CKD patients vary according to age and demonstrate different patterns between sexes, but no significant sex-based differences were identified. These findings suggest that urea dynamics are influenced by multiple factors, highlighting the importance of individualized management strategies in CKD patients undergoing hemodialysis.
Downloads
References
[1] Metskhvarishvili G, Simonia G, Sarishvili N, Tchokhonelidze I. Can Severe Uremia Impact Mortality Predictors in Elderly People With Kidney Failure? Cureus. 2024 Oct 30;16(10):e72715. doi: 10.7759/cureus.72715
[2] Moon Kim S, Yong Jung J. Nutritional management in patients with chronic kidney disease. Korean J Intern Med. 2020 Sep 23;35(6):1279–1290. doi: 10.3904/kjim.2020.408
[3] Somji SS, Ruggajo P, Moledina S . Adequacy of Hemodialysis and Its Associated Factors among Patients Undergoing Chronic Hemodialysis in Dar es Salaam, Tanzania. Int J Nephrol. 2020 Feb 10;2020:9863065. doi: 10.1155/2020/9863065
[4] Lakshminarayana GR, Sheetal LG, Mathew A, Rajesh R, Kurian G, Unni VN. Hemodialysis outcomes and practice patterns in end-stage renal disease: Experience from a Tertiary Care Hospital in Kerala. Indian J Nephrol. 2017 Jan-Feb;27(1):51–57. doi: 10.4103/0971-4065.177210
[5] Franco-Acevedo AEchavarria R andZesergio Melo Z. . Sex Differences in Renal Function: Participation of Gonadal Hormones and Prolactin. Endocrines 2021, 2(3), 185-202; https://doi.org/10.3390/endocrines2030019
[6] Hu, Yanyan and Hu, Yanyan and Hu, Yifang and Hu, Yifang and Wang, Yifei and Wang, Yifei and Xue, Cheng and Xue, Cheng and Liu, Yun and Lu, Shan, Higher Estimated Pulse Wave Velocity Predicts Long-Term Mortality in Stage 0-3 Cardiovascular-Kidney-Metabolic Syndrome Patients across Two Cohorts. 2025. Available at SSRN: https://ssrn.com/abstract=5461368 or http://dx.doi.org/10.2139/ssrn.5461368
[7] Caccia F, Baciga F, Baschirotto C, et al . Physical Activity and Exercise in patients with coexisting Chronic Kidney Disease and Peripheral Artery Disease: Time to Bridge the Gap? Journal of Renal Nutrition . 23 March 2026
[8] Yan Z , Guanran Wang G, Xingyang Shi X. Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease. Front. Pharmacol., 21 December 2021. Sec. Renal Pharmacology.Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.785375
[9] Isabelle Six , Nadia Flissi , Gaëlle Lenglet. Review. et al. Uremic toxins and metabolism. Kidney Int. 2020; 98:146–158.
[10] Harvey BJ and de la Rosa DA,. Sex Differences in Kidney Health and Disease. Nephron (2025) 149 (2): 77–103. https://doi.org/10.1159/000541352
[11] Chatrenet A, Piccoli G, Audebrand JM,. Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease. Journal of Cachexia, Sarcopenia and Muscle 2023; 14: 2016–202
[12] Morris A, Riya Patel R, Papadopoulos K, et al. Nutritional Self-Management of Chronic Kidney Disease: A Systematic Review and Co-Created Qualitative Synthesis. Journal of Renal Nutrition .Volume 36, Issue 2, March 2026, Pages 261-276.
[13] Cau A, Stigant C, Singh S, et al. Frequency of Routine Bloodwork Among Patients With Chronic Kidney Disease: A Narrative Review to Inform Appropriateness of Care. Canadian Journal of Kidney Health and Disease. 2026. Volume 13 https://doi.org/10.1177/20543581261421899.
[14] Desbiens LC , Bargman JM , Chan CT, Nadeau-Fredette AC. Integrated home dialysis model: facilitating home-to-home transition. Clinical Kidney Journal, Volume 17, Issue Supplement_1, 2024, Pages i21–i33, https://doi.org/10.1093/ckj/sfae079
[15] Xiao F, et al. Comparison of brain gray matter volume changes in peritoneal dialysis and hemodialysis patients with chronic kidney disease: a VBM study. Front. Neurosci., Sec. Translational Neuroscience
[16] Volume 18 - 2024 . https://doi.org/10.3389/fnins.2024.1394169ront
[17] Janvi Khanna, Kumar S, Jain A et al, Clinical Pertinence and Determinants of Potential Drug–Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study. Journal of Pharmacy Technology Volume 40, Issue 3. 2024.https://doi.org/10.1177/87551225241241977.
[18] Nikolaou E, tziastoudi M, Gougora SG, et al. Sex hormone binding globulin (SHBG) serum levels and insulin resistance in men on chronic hemodialysis. Diabetol Metab Syndr. Diabetolic and Metabolic Syndrome. 2024 Jul 16;16:166. doi: 10.1186/s13098-024-01406-9 2024.
[19] Perez Tulcanaza C, Benítez-Baldassari A, Banegas-Sarmiento A, Jose Daniel Sanchez
[20] . Risk Factors Associated with Hyporesponsiveness to Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis Who Present Anemia: A Multicenter Case-Control Study. Kidney Dialysis. Vol. 5, Issue 2, pp. 23–34. 2025.
[21] Prastiwi F, , Titin Andri W , Dina Dewi SL. Factors Associated with Fatigue in Chronic Kidney Disease Patients Undergoing Hemodialysis: A Systematic Review. Jurnal Kedokteran Brawijaya Vol. 31, No. 4, August 2021, pp. 260-268. 2021.
[22] Hosseini SF, Abdollahi M, Salehian S, Khosravizade Tabasi H. Epidemiological Characteristics and Associated Factors of Chronic Kidney Disease Among Hemodialysis Patients in Dialysis Centers of Birjand and Tabas Counties in 2023. Compr Health Biomed Stud. 2025;3(4):e160452. doi: https://doi.org/10.5812/chbs-160452.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Yoni Astuti

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




















